Dr. Enrico Pierluigi Spugnini graduated from the Veterinary School of Perugia (Italy) in 1992. After that, he attended the six-month intensive postgraduate course in clinical veterinary medicine at the Animal Medical Center of New York (NY). During this period, he was accepted for a residency program by North Carolina State University. Since 1997, he has worked as a freelance veterinary oncologist in Rome, Italy, and he works as a consultant with the Regina Elena Cancer Institute of Rome, Italy. Since July 1999, he has collaborated with the Centre of Biomedical Engineering of Sofia, Bulgaria, to develop novel instrumentations for electrochemotherapy. He completed his Ph.D. studies in preclinical electrochemotherapy at the Bulgarian Academy of Sciences in 2006. He is a diplomate of both the ACVIM and the ECVIM–CA. Throughout these years, he devoted himself to the cure of cancer in companion animals, developing, among other things, novel therapeutic protocols. He is an author of 130 publications in peer-reviewed journals. Since November 2006, he has been a preclinical investigator on electrochemotherapy at the Centre of Biomedical Engineering “Ivan Daskalov” of Sofia, Bulgaria. He is a member of the Scientific Committee of the Italian Endometriosis Association. He is a reviewer for several international scientific journals and has board membership in two international journals, The Open Drug Resistance Journal and the Journal of Experimental and Clinical Cancer Research.

Dr. Maria Condello graduated “cum laude” in Biological Science, and she received a Ph.D. degree in Pharmacology, Pharmacognosy and Toxicology at the University of Rome “La Sapienza”. She works as a researcher at the National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità in Rome, where she is studying new anticancer therapy on in vitro models based on the use of natural products administered free or delivered by liposomes, and on electrochemotherapy. She carries out citofluorimetric analysis to understand cell death mechanisms after treatment with new anticancer agents, and morphological, ultrastructural, and biochemical assays investigating cell modifications, oxidative stress, and cell death evaluation. She studies the antitumor effects of compounds extracted from Prunus spinosa, a typical plant of Molise. In the field of nanotechnology, she evaluates the toxicity induced by ZnO nanoparticles on tumor cells, and she contributes to the understanding of nanoparticle uptake mechanisms in colon cancer cells and their interaction with the cell plasma membrane. She is an author of 47 national and international publications. She has participated in national and international conferences and workshops, with 65 communications. She is a member of the Italian Society of Cellular Cultures, the Italian Society for Cytometry and the Italian Society for Microscopical Sciences, and she has received numerous awards and honors.

Dr. Stefania Crispi is a group leader at the Institute of Biosciences and BioResources UOS of Naples – CNR, Gene Expression and Molecular Genetics Laboratory. She received her Ph.D. in Cellular and Molecular Genetics in 1994. Then she completed her postdoctoral fellowship at the University of Naples "Federico II" from 1995 to 1997, and obtained her second-level master’s degree in phytotherapy at the University of Siena in 2005. Her clinical interests include molecular genetics, cellular genetics, molecular biology, Drosophila genetics, and gene regulation. She is an author of 60 publications in peer-reviewed journals, with 1856 citations and an h-index of 28 (Scopus, 20 December 2023).

Prof. Alfonso Baldi is an Associate Professor at the Department of Environmental, Biological and Pharmaceutical Sciences, University of Campania Luigi Vanvitelli, Caserta, Italy. He is the Director of the Laboratory of Pathology, CEINGE, Naples. He obtained his M.D. degree with full marks and honors at the University of Naples Federico II in 1992. After that, he completed his residency program in surgical pathology at the same university from 1992 to 1996. His research interests include DNA, genetics, cancer biology, apoptosis, immunohistochemistry, treatment, cell culture, gene expression, cell signaling, and biotechnology. He is an author of 394 publications in peer-reviewed journals, with 13779 citations and a high h-index of 59 (Scopus, 20 December 2023).